安全用血的管理

陈义柱, 马建明, 叶玉芳, 等. 安全用血的管理[J]. 临床血液学杂志, 2012, 25(8): 539-542.
引用本文: 陈义柱, 马建明, 叶玉芳, 等. 安全用血的管理[J]. 临床血液学杂志, 2012, 25(8): 539-542.

安全用血的管理

详细信息
    通讯作者: 陈义柱,E-mail:13735180918@163.com
  • 中图分类号: R457.1

  • 加载中
  • [1]

    MANZINI P,GIROTTO M,BORSOTTI R,et al.Italian blood donors with anti-HBc and occult hepatitis B virus infection[J].Haematologica,2007,92:1664-1670.

    [2]

    BROJER E,GRABARCZYK P,LISZEWSKI C,et al.Characterization of HBV DAN+/HBsAg-blood donors in Poland identified by triplex NAT[J].Hepatology,2006,44:1666-1674.

    [3]

    KATSOULIDOU A,PARASKEVIS D,MAGIORKINIS E,et al.Molecular characterization of occult hepatitis B cases in Greek blood donors[J].J Med Virol,2009,81:815-825.

    [4]

    欧山海,林永财,倪宏英,等.闽南地区无偿献血者隐匿性乙型肝炎病毒感染研究[J].中国输血杂志,2010,23(12):1033-1037.

    [5]

    袁红,杨继东,李振宇,等.献血员乙型肝炎病毒感染筛查安全性初步评价[J].现代预防医学,2008,35(6):1130-1134.

    [6]

    LEVICNIK-STEZINAR S,RAHNE-POTOKAR V,CANDOTTI D,et al.Anti-HBspositive occult hepatitis B virus carrier blood infections in two transfusion recipients[J].J Hepatol,2OO8,48:1022—1027.

    [7]

    SATAKE M,TAIRA R,YUGI H.et al.Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program [J].Transfusion,2007,47:1197—1205.

    [8]

    URBANI S,FAGNONI F,MISSALE G,et al.The role of anti-core antibody response in the detection of occult hep-atitis B virus infection[J].Clin Chem Lab Med,2010,48:23—29.

    [9]

    VITALE F,TRAMUTO F,QRLANDO A,et al.Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection [J]. J Men Virol,2008,8O:577-582.

    [10]

    季阳,苑宇哲,蔡辉,等.输血传播人类嗜T淋巴细胞病毒感染及其预防对策[J].中国输血杂志,2010,23(12):1003-1005.

    [11]

    朱立苇,徐健,王拥军,等.单采血小板献血者次数对血小板细菌污染的影响[J].中国输血杂志,2010,23(10):828-829.

    [12]

    蒋冬玲,李志强.实用临床输血指南[M].北京:人民卫生出版社,2006:44-48.

    [13]

    王星华,方国恩,戚中田.输血感染与输血安全[J].中国实用外科杂志,2009,29(4):323-326.

    [14]

    高峰.输血与输血技术学[M].北京:人民卫生出版社,2003:180-231.

    [15]

    FONG Y,KARPEH M,MAYER K,etal.Association of perionperative transfusions with poor outcome in resection of gastric adenocarcinoma[J].Am J Surg,1994,167:256-260.

    [16]

    KIM W W,LEEKW,CHOI S H,etal.Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma[J].Korean J Hepatol,2004,10:51-61.

    [17]

    INABA S.Allogenic blood transfusion for surgery [J].Nippn Geka Gakkai Zasshi,2005,106:13-17.

    [18]

    TAKEMURA M,OSUGI H,TAKADA N,et al.Immunologic effects of allogeneic versus autologous blood transfusion in patients undergoing radical ocaophagectomy[J].Eur Surg Res,2003,35:115-122.

    [19]

    TAMURA K,SHIBATA Y,MATSUDA Y,et al.Isoltion and characterzation of an immunosuppressive acidic protein from fluids of cancer patients[J].Cancer Res,1981,41:3244-3250.

    [20]

    苏智雄,黎乐群,肖开银,等.围手术期输血对原发性肝癌患者免疫抑制酸性蛋白的影响[J].中国输血杂志,2006,19(3):209-210.

  • 加载中
计量
  • 文章访问数:  85
  • PDF下载数:  202
  • 施引文献:  0
出版历程
收稿日期:  2011-12-13

目录